P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS

• S. Saußele,
• N. Evans,
• F. E. Nicolini,
• E. Chelysheva,
• D. Réa,
• F. Castagnetti,
• S. Claudiani,
• R. Rodrigues,
• C. Kok,
• T. Hughes

Affiliations

S. Saußele

1 III. Med. Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany

N. Evans

2 International CML Foundation, London, United Kingdom

F. E. Nicolini

3 Hematology department, Centre Léon Bérard and INSERM1052, Lyon, France

E. Chelysheva

4 National Research Center for Hematology, Moscow, Russia

D. Réa

5 Hematology department, Saint-Louis Hospital, Paris, France

F. Castagnetti

6 Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

S. Claudiani

7 Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

R. Rodrigues

8 Departamento de Hematologia, Instituto Português de Oncologia de Lisboa - IPO, Lisbon, Portugal

C. Kok

9 Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

T. Hughes

2 International CML Foundation, London, United Kingdom